These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 27782822)
1. In vitro and in vivo activity of miR-92a-Locked Nucleic Acid (LNA)-Inhibitor against endometrial cancer. Torres A; Kozak J; Korolczuk A; Wdowiak P; Domańska-Glonek E; Maciejewski R; Torres K BMC Cancer; 2016 Oct; 16(1):822. PubMed ID: 27782822 [TBL] [Abstract][Full Text] [Related]
2. Locked nucleic acid-inhibitor of miR-205 decreases endometrial cancer cells proliferation in vitro and in vivo. Torres A; Kozak J; Korolczuk A; Rycak D; Wdowiak P; Maciejewski R; Torres K Oncotarget; 2016 Nov; 7(45):73651-73663. PubMed ID: 27655663 [TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells. Di Martino MT; Gullà A; Gallo Cantafio ME; Altomare E; Amodio N; Leone E; Morelli E; Lio SG; Caracciolo D; Rossi M; Frandsen NM; Tagliaferri P; Tassone P PLoS One; 2014; 9(2):e89659. PubMed ID: 24586944 [TBL] [Abstract][Full Text] [Related]
4. Erratum to: In vitro and in vivo activity of miR-92a-Locked Nucleic Acid (LNA)-Inhibitor against endometrial cancer. Torres A; Kozak J; Korolczuk A; Wdowiak P; Domańska-Glonek E; Maciejewski R; Torres K BMC Cancer; 2016 Dec; 16(1):939. PubMed ID: 27927170 [No Abstract] [Full Text] [Related]
5. Blockage of miR-92a-3p with locked nucleic acid induces apoptosis and prevents cell proliferation in human acute megakaryoblastic leukemia. Sharifi M; Salehi R Cancer Gene Ther; 2016 Jan; 23(1):29-35. PubMed ID: 26658357 [TBL] [Abstract][Full Text] [Related]
6. Butyrate inhibits pro-proliferative miR-92a by diminishing c-Myc-induced miR-17-92a cluster transcription in human colon cancer cells. Hu S; Liu L; Chang EB; Wang JY; Raufman JP Mol Cancer; 2015 Oct; 14():180. PubMed ID: 26463716 [TBL] [Abstract][Full Text] [Related]
8. miR-92a inhibits peritoneal dissemination of ovarian cancer cells by inhibiting integrin α5 expression. Ohyagi-Hara C; Sawada K; Kamiura S; Tomita Y; Isobe A; Hashimoto K; Kinose Y; Mabuchi S; Hisamatsu T; Takahashi T; Kumasawa K; Nagata S; Morishige K; Lengyel E; Kurachi H; Kimura T Am J Pathol; 2013 May; 182(5):1876-89. PubMed ID: 23499550 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of microRNA miR-92a induces apoptosis and necrosis in human acute promyelocytic leukemia. Sharifi M; Salehi R; Gheisari Y; Kazemi M Adv Biomed Res; 2014; 3():61. PubMed ID: 24627869 [TBL] [Abstract][Full Text] [Related]
10. On the in vitro and in vivo properties of four locked nucleic acid nucleotides incorporated into an anti-H-Ras antisense oligonucleotide. Fluiter K; Frieden M; Vreijling J; Rosenbohm C; De Wissel MB; Christensen SM; Koch T; Ørum H; Baas F Chembiochem; 2005 Jun; 6(6):1104-9. PubMed ID: 15861430 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic inhibition of microRNA-21 (miR-21) using locked-nucleic acid (LNA)-anti-miR and its effects on the biological behaviors of melanoma cancer cells in preclinical studies. Javanmard SH; Vaseghi G; Ghasemi A; Rafiee L; Ferns GA; Esfahani HN; Nedaeinia R Cancer Cell Int; 2020; 20():384. PubMed ID: 32788885 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-α. Chen S; Sun KX; Liu BL; Zong ZH; Zhao Y Mol Cancer; 2016 Feb; 15():11. PubMed ID: 26832151 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of miR-92a increases endothelial proliferation and migration in vitro as well as reduces neointimal proliferation in vivo after vascular injury. Iaconetti C; Polimeni A; Sorrentino S; Sabatino J; Pironti G; Esposito G; Curcio A; Indolfi C Basic Res Cardiol; 2012 Sep; 107(5):296. PubMed ID: 22890560 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of miR-92a enhances fracture healing via promoting angiogenesis in a model of stabilized fracture in young mice. Murata K; Ito H; Yoshitomi H; Yamamoto K; Fukuda A; Yoshikawa J; Furu M; Ishikawa M; Shibuya H; Matsuda S J Bone Miner Res; 2014 Feb; 29(2):316-26. PubMed ID: 23857760 [TBL] [Abstract][Full Text] [Related]
15. miR-92a promotes tumor growth of osteosarcoma by targeting PTEN/AKT signaling pathway. Xiao J; Yu W; Hu K; Li M; Chen J; Li Z Oncol Rep; 2017 Apr; 37(4):2513-2521. PubMed ID: 28260104 [TBL] [Abstract][Full Text] [Related]
16. miR-92a/DUSP10/JNK signalling axis promotes human pancreatic cancer cells proliferation. He G; Zhang L; Li Q; Yang L Biomed Pharmacother; 2014 Feb; 68(1):25-30. PubMed ID: 24332650 [TBL] [Abstract][Full Text] [Related]
17. Development of a miR-92a delivery system for anti-angiogenesis-based cancer therapy. Ando H; Okamoto A; Yokota M; Shimizu K; Asai T; Dewa T; Oku N J Gene Med; 2013 Jan; 15(1):20-7. PubMed ID: 23239404 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of MicroRNA miR-222 with LNA Inhibitor Can Reduce Cell Proliferation in B Chronic Lymphoblastic Leukemia. Dehkordi KA; Chaleshtori MH; Sharifi M; Jalili A; Fathi F; Roshani D; Nikkhoo B; Hakhamaneshi MS; Sani MRM; Ganji-Arjenaki M Indian J Hematol Blood Transfus; 2017 Sep; 33(3):327-332. PubMed ID: 28824233 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and Pharmacodynamics of a 13-mer LNA-inhibitor-miR-221 in Mice and Non-human Primates. Gallo Cantafio ME; Nielsen BS; Mignogna C; Arbitrio M; Botta C; Frandsen NM; Rolfo C; Tagliaferri P; Tassone P; Di Martino MT Mol Ther Nucleic Acids; 2016 Jun; 5(6):. PubMed ID: 27327137 [TBL] [Abstract][Full Text] [Related]
20. MiR-92 suppresses proliferation and induces apoptosis by targeting EP4/Notch1 axis in gastric cancer. Shin VY; Siu MT; Liu X; Ng EKO; Kwong A; Chu KM Oncotarget; 2018 May; 9(36):24209-24220. PubMed ID: 29849934 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]